CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 3,168,388 | $50,251,000 | 5.05% |
ATP Life Science Ventures, L.P. | 4,028,937 | $63,859,000 | 4.93% |
Affinity Asset Advisors, LLC | 150,000 | $2,379,000 | 1.26% |
Altium Capital Management LP | 205,799 | $3,264,000 | 1.22% |
EcoR1 Capital, LLC | 1,250,001 | $19,825,000 | 1.07% |
Vivo Capital, LLC | 1,206,266 | $19,131,000 | 0.85% |
Marquette Asset Management, LLC | 182,036 | $2,887,000 | 0.66% |
Monashee Investment Management LLC | 272,949 | $4,329,000 | 0.57% |
Ally Bridge Group (NY) LLC | 199,600 | $3,166,000 | 0.54% |
Rubric Capital Management LP | 325,863 | $5,168,000 | 0.38% |